NeuroBo Pharmaceuticals Inc. (NRBO) Social Stream



NeuroBo Pharmaceuticals Inc. (NRBO): $0.37

0.00 (-0.32%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add NRBO to Watchlist
Sign Up

Industry: Biotech


Ranked

of 475

in industry

NeuroBo Pharmaceuticals Inc (NRBO) Price Targets From Analysts

The tables below show the price targets and recommendations analysts covering NRBO.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-08-31 1 $16 $16 $16 $0.84 1804.76%

Price Target Last Issued August 31, 2021

The Trend in the Analyst Price Target


NRBO's average price target has moved down $9 over the prior 33 weeks.

Over the past 170 days, NRBO's average upside potential has been 363.02%.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2021-05-08 0 16 16 16 2.95 442.37%
2021-06-13 0 16 16 16 3.11 414.47%
2021-07-10 0 16 16 16 3.06 422.88%
2021-08-31 1 16 16 16 4.14 286.47%
2021-09-19 1 16 16 16 4.25 276.47%

NRBO Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1 1 0 0 0 0 1

The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for NRBO as an investment opportunity.

  • To contextualize these metrics, consider that out of all US stocks, NeuroBo Pharmaceuticals Inc's number of analysts covering the stock is greater than nearly none of them.
  • To contextualize these metrics, consider that out of all US stocks, NeuroBo Pharmaceuticals Inc's variance in analysts' estimates is lower than almost 100% of them.
  • In the context of Healthcare stocks, NeuroBo Pharmaceuticals Inc's upside potential (average analyst target price relative to current price) is higher than 99.32% of them.
  • In the context of Healthcare stocks, NeuroBo Pharmaceuticals Inc's average analyst price target is higher than 25.89% of them.

In the Pharmaceutical Products industry, NBY, NBSE, and MTCR are the three stocks most similar to NeuroBo Pharmaceuticals Inc regarding the price target and analyst recommendation information presented here.

What is the outlook for NRBO? Use POWR Ratings for clearer insight into price direction.


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.4244 seconds.